Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Company Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:08 2024-05-17 pm EDT 		5-day change 1st Jan Change
44.01 USD -0.23% Intraday chart for Bristol-Myers Squibb Company -2.07% -14.23%
May. 16 Everlasting momentum Our Logo
May. 16 Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma DJ

Business Summary

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.

The United States account for 70.1% of net sales.

Number of employees: 34,100

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Medicines
100.0 %
46,159 100.0 % 45,006 100.0 % -2.50%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
70.1 %
31,828 69.0 % 31,555 70.1 % -0.86%
International
28.3 %
13,497 29.2 % 12,752 28.3 % -5.52%
Other
1.6 %
834 1.8 % 699 1.6 % -16.19%

Managers

Managers TitleAgeSince
Christopher Boerner CEO
 Chief Executive Officer 53 15-01-31
David Elkins DFI
 Director of Finance/CFO 55 19-11-19
Greg Meyers CTO
 Chief Tech/Sci/R&D Officer - -
Kimberly McCutcheon Jablonski CMP
 Compliance Officer - 02-12-31
Estelle Vester-Blokland CTO
 Chief Tech/Sci/R&D Officer - -
Samit Hirawat CTO
 Chief Tech/Sci/R&D Officer 55 18-12-31
Robert Plenge CTO
 Chief Tech/Sci/R&D Officer 53 19-10-31
Laura Hortas IRO
 Public Communications Contact - -
Cynthia Piccirillo PRN
 Corporate Officer/Principal - -
Cari Gallman PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Phyllis Yale BRD
 Director/Board Member 66 19-11-19
Peter Arduini BRD
 Director/Board Member 59 16-03-31
Derica Rice BRD
 Director/Board Member 59 20-08-31
Paula Price BRD
 Director/Board Member 62 20-08-31
Theodore Samuels BRD
 Director/Board Member 69 17-02-20
David Elkins DFI
 Director of Finance/CFO 55 19-11-19
Christopher Boerner CEO
 Chief Executive Officer 53 15-01-31
Julia Haller BRD
 Director/Board Member 69 19-11-19
Deepak Bhatt BRD
 Director/Board Member 56 22-06-13
Karen Vousden BRD
 Director/Board Member 66 17-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,923,100,096 2,024,918,592 ( 69.27 %) 896,000,000 ( 30.65 %) 69.27 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.181 %
186,067,109 9.181 % 8 317 M $
BlackRock Advisors LLC
6.185 %
125,355,772 6.185 % 5 603 M $
STATE STREET CORPORATION
4.518 %
91,571,110 4.518 % 4 093 M $
JPMorgan Investment Management, Inc.
4.368 %
88,525,438 4.368 % 3 957 M $
Capital Research & Management Co. (International Investors)
3.464 %
70,203,814 3.464 % 3 138 M $
Charles Schwab Investment Management, Inc.
2.650 %
53,715,966 2.650 % 2 401 M $
Fidelity Management & Research Co. LLC
2.100 %
42,557,702 2.100 % 1 902 M $
Geode Capital Management LLC
2.038 %
41,304,605 2.038 % 1 846 M $
BlackRock Life Ltd.
1.574 %
31,893,511 1.574 % 1 426 M $
Norges Bank (13F)
1.501 %
30,413,639 1.501 % 1 359 M $
NameEquities%Valuation
Bram Bradesco Asset Management S/A DTVM
0.000233 %
4,731 0.000233 % 209 518 $
NameEquities%Valuation
Transcend Wealth Collective LLC
-
117,775 - 7 184 $
FourWorld Capital Management LLC
-
100,000 - 6 100 $
Davenport & Co. LLC
-
83,970 - 5 122 $
CapFinancial Partners LLC
-
20,498 - 1 250 $
FIFTH THIRD BANCORP
-
20,000 - 1 220 $
Private Advisor Group LLC
-
15,000 - 915 $
Paradigm Financial Partners LLC
-
10,000 - 610 $
Northwestern Mutual Wealth Management Co.
-
242 - 15 $
OAKWORTH CAPITAL INC.
-
125 - 8 $
Atlantic Edge Private Wealth Management LLC
-
16 - 1 $

Holdings

NameEquities%Valuation
AVIDITY BIOSCIENCES, INC.
6.37%
 5,075,304 6.37% 120,944,494 $
KURA ONCOLOGY, INC.
1.80%
 1,370,171 1.80% 26,033,249 $
KURA ONCOLOGY, INC.
6.36%
 759,145 6.36% 21,438,255 $
COMPUGEN LTD.
5.31%
 4,757,058 5.31% 9,546,749 $
CELULARITY INC.
5.49%
 1,195,327 5.49% 3,669,654 $

Company contact information

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com
address Bristol-Myers Squibb Company(BMY)

Group companies

NameCategory and Sector
Bristol-Myers Squibb India Pvt Ltd.
Logo Bristol-Myers Squibb India Pvt Ltd.

Bristol-Myers Squibb India Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. discovers, develops and delivers medicines for immuno-oncology. The company is based in Mumbai, India.

Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV
Logo Bristol-Myers Squibb de México S de RL de CV

Bristol-Myers Squibb de México S de RL de CV

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The company is located in Mexico.

Pharmaceuticals: Major
Celgene Kappa Holdings LLC
Bristol-Myers Squibb International Co. ULC
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
Seamair Insurance DAC
Bristol-Myers Squibb AE
Swords Laboratories Unlimited Co.
Logo Swords Laboratories Unlimited Co.

Swords Laboratories Unlimited Co.

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Swords, Ireland.

Pharmaceuticals: Major
BMS Strategic Portfolio Investments Holdings, Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
44.03 USD
Average target price
53.19 USD
Spread / Average Target
+20.81%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BRISTOL-MYERS SQUIBB COMPANY Stock Bristol-Myers Squibb Company
-14.23% 89.25B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Company Bristol-Myers Squibb Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW